메뉴 건너뛰기




Volumn 109, Issue 5, 2012, Pages 685-690

Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: Secondary analysis of a prospective trial

Author keywords

biomarkers; bladder cancer; detection; nuclear matrix protein 22; surveillance; urothelial carcinoma

Indexed keywords

NUCLEAR MATRIX PROTEIN 22;

EID: 84857355892     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.010419.x     Document Type: Article
Times cited : (26)

References (23)
  • 4
    • 77953850928 scopus 로고    scopus 로고
    • Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
    • Lotan Y, Shariat SF, Schmitz-Drager BJ, et al,. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urol Oncol 2010; 28: 441-8
    • (2010) Urol Oncol , vol.28 , pp. 441-448
    • Lotan, Y.1    Shariat, S.F.2    Schmitz-Drager, B.J.3
  • 6
    • 57649126208 scopus 로고    scopus 로고
    • Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer
    • Herman MP, Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF,. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. Minerva Urol Nefrol 2008; 60: 217-35
    • (2008) Minerva Urol Nefrol , vol.60 , pp. 217-235
    • Herman, M.P.1    Svatek, R.S.2    Lotan, Y.3    Karakiewizc, P.I.4    Shariat, S.F.5
  • 9
    • 0032964744 scopus 로고    scopus 로고
    • Urinary nuclear matrix protein 22 (NMP22): A diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder
    • DOI 10.1002/(SICI)1097-0339(199905)20:5<285::AID-DC7>3.0.CO;2-T
    • Hughes JH, Katz RL, Rodriguez-Villanueva J, et al,. Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder. Diagn Cytopathol 1999; 20: 285-90 (Pubitemid 29205522)
    • (1999) Diagnostic Cytopathology , vol.20 , Issue.5 , pp. 285-290
    • Hughes, J.H.1    Katz, R.L.2    Rodriguez-Villanueva, J.3    Kidd, L.4    Dinney, C.5    Grossman, H.B.6    Fritsche Jr., H.A.7
  • 11
    • 66149108802 scopus 로고    scopus 로고
    • Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection
    • Lotan Y, Capitanio U, Shariat SF, Hutterer GC, Karakiewicz PI,. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int 2009; 103: 1368-74
    • (2009) BJU Int , vol.103 , pp. 1368-1374
    • Lotan, Y.1    Capitanio, U.2    Shariat, S.F.3    Hutterer, G.C.4    Karakiewicz, P.I.5
  • 18
    • 77953817519 scopus 로고    scopus 로고
    • Statistical consideration for clinical biomarker research in bladder cancer
    • Shariat SF, Lotan Y, Vickers A, et al,. Statistical consideration for clinical biomarker research in bladder cancer. Urol Oncol 2010; 28: 389-400
    • (2010) Urol Oncol , vol.28 , pp. 389-400
    • Shariat, S.F.1    Lotan, Y.2    Vickers, A.3
  • 19
    • 55049116162 scopus 로고    scopus 로고
    • Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers
    • Vickers AJ,. Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers. Am Stat 2008; 62: 314-20
    • (2008) Am Stat , vol.62 , pp. 314-320
    • Vickers, A.J.1
  • 20
    • 33750905259 scopus 로고    scopus 로고
    • Decision curve analysis: A novel method for evaluating prediction models
    • DOI 10.1177/0272989X06295361
    • Vickers AJ, Elkin EB,. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-74 (Pubitemid 44728772)
    • (2006) Medical Decision Making , vol.26 , Issue.6 , pp. 565-574
    • Vickers, A.J.1    Elkin, E.B.2
  • 21
    • 0030069896 scopus 로고    scopus 로고
    • Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
    • DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2- 4
    • Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87 (Pubitemid 26072233)
    • (1996) Statistics in Medicine , vol.15 , Issue.4 , pp. 361-387
    • Harrell Jr., F.E.1    Lee, K.L.2    Mark, D.B.3
  • 22
    • 0023710206 scopus 로고
    • Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
    • DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45
    • (1988) Biometrics , vol.44 , pp. 837-845
    • Delong, E.R.1    Delong, D.M.2    Clarke-Pearson, D.L.3
  • 23
    • 67349138615 scopus 로고    scopus 로고
    • Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker
    • Lotan Y, Elias K, Svatek RS, et al,. Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker. J Urol 2009; 182: 52-7
    • (2009) J Urol , vol.182 , pp. 52-57
    • Lotan, Y.1    Elias, K.2    Svatek, R.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.